W.W. de Herder

W.W. de Herder is a Full Professor in the Department of Internal Medicine at Erasmus MC, a leading academic medical center in the Netherlands. His work is centered within the Faculty of Medicine, where he contributes significantly to clinical and translational research in endocrinology.

His research interests focus on neuroendocrine tumors, peptide receptor radionuclide therapy, and endocrine oncology. He has published extensively on conditions such as acromegaly, MEN1 syndrome, and metastatic neuroendocrine tumors, with a strong emphasis on molecular mechanisms, diagnostic approaches, and targeted therapies.

The recent trends in his publications highlight a deep engagement with innovative treatments like lutetium-177-based therapy, the role of gut microbiota in carcinoid syndrome, and the epigenetic and clinicopathological features of neuroendocrine metastases. His work bridges clinical practice and advanced research, often involving multidisciplinary collaboration.

His scientific achievements have been recognized through several prestigious awards:

• NVE – Novo Nordisk Award for Endocrinology (2023)
• ESE Annual Special Recognition Award (2018)
• Dr. Henry Friesen Award (2017)

He has supervised 14 research projects or junior researchers, indicating a strong commitment to mentoring the next generation of scientists and clinicians. Although no specific grants are listed, his extensive publication record and international collaborations suggest sustained funding and research support. His work is highly cited and widely referenced across platforms like Mendeley, Scopus, and academic social media.

Dr. de Herder is actively involved in major research networks in endocrinology and oncology, with collaborations spanning multiple countries. His fingerprint analysis reveals dominant activity in neuroendocrine tumors (100%), peptide receptor targeting (36%), and radionuclide therapy (35%), underscoring his leadership in these specialized domains.